Invasive Aspergillosis
📧 Sign up to get email alerts when something new happens for Invasive Aspergillosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Natural History of Individuals With Immune System Problems That Lead to Fungal Infections
This clinical trial update notes ongoing recruitment for a natural history study of individuals with immune system defects that predispose t…
-
FDA approval · 2026-02-19FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for Vfend (voriconazole) submitted by Roerig.
-
FDA approval · 2026-01-28FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig.
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)
Clinical trial update noting that the study on COVID-19 associated pulmonary aspergillosis and other invasive fungal infections has complete…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic Dysfunction [NA]
A clinical trial update describes a study evaluating liposomal amphotericin B for invasive aspergillosis in patients with hepatic dysfunctio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Olorofim Aspergillus Infection Study [Phase 3]
This clinical trial update indicates that olorofim is being studied in a Phase 3 trial for invasive aspergillosis, with the study currently …
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value
This clinical trial evaluates using PCR for Aspergillus fumigatus in blood and bronchoalveolar lavage to monitor invasive aspergillosis and …
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Incidence of Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia
A completed clinical trial update reports on the incidence of invasive aspergillosis in patients with ventilator-associated pneumonia.
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Study to Understand How the Use of Paxlovid Affected the Healthcare Use in People With Pre-existing Conditions.
This completed trial evaluated whether Paxlovid (nirmatrelvir/ritonavir) influenced healthcare utilization in people with pre-existing condi…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Performance Evaluation of the Fujifilm Wako Beta-D-glucan Technique in the Diagnosis of Major Invasive Fungal Infections (IFI)
This clinical trial update evaluates the performance of the Fujifilm Wako beta-D-glucan assay in diagnosing major invasive fungal infections…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive Aspergillosis
A prospective multicenter evaluation of the MycoGenie Kit for diagnosing invasive aspergillosis in patients with onco-hematological diseases…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Immunomonitoring of Mold Invasive Infections
A clinical trial evaluating immunomonitoring of mold invasive fungal infections is currently recruiting, sponsored by Assistance Publique - …
-
FDA approval · 2025-11-14FDA Approved: VORICONAZOLE — Original Application (Hainan Poly Pharm. Co., Ltd.)
The FDA approved a generic Voriconazole product from Hainan Poly Pharm. Co., Ltd. via an Original Application (ANDA 220043). It covers voric…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Isavuconazole in Critically Ill Patients: Efficacy and Safety
Clinical trial update for isavuconazole in critically ill patients indicating the study is not yet recruiting; conditions include invasive a…
-
FDA approval · 2025-07-18FDA Approved: CASPOFUNGIN ACETATE — Original Application (Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.)
The FDA approved Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.'s caspofungin acetate as an original generic application (ANDA) for mark…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi [Phase 4]
Phase 4 trial update indicating completion of the study of Pfizer's Cresemba (posaconazole) for invasive fungal disease due to Aspergillus s…
-
FDA approval · 2025-07-03FDA Approved: POSACONAZOLE — Supplemental Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved a supplemental application for posaconazole submitted by Glenmark Pharmaceuticals Inc., USA, under an ANDA.
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: European Study of Cerebral Aspergillosis Treated With Isavuconazole
This completed European trial evaluates isavuconazole for cerebral aspergillosis, within the broader context of invasive aspergillosis.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus [Phase 3]
Phase 3 trial of ABCD for Injection for invasive candidiasis and invasive aspergillosis has completed.
-
FDA approval · 2025-03-24FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) from Astellas Pharma US, Inc.
-
FDA approval · 2025-03-24FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for CRESEMBA (isavuconazonium sulfate) filed by Astellas Pharma US, Inc.
-
FDA approval · 2025-03-13FDA Approved: POSACONAZOLE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for posaconazole from Mylan Institutional LLC, updating the approval for the generic product.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants [Phase 4]
A Phase 4 clinical trial update evaluating posaconazole pharmacokinetics in patients receiving chemotherapy or stem cell transplants; recrui…
-
EMA approval · 2025-01-21EMA Authorised: Posaconazole AHCL (posaconazole) — Accord Healthcare S.L.U.
EMA authorised Posaconazole AHCL by Accord Healthcare S.L.U. for mycoses. The EU marketing authorization was granted on 16 January 2025.
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104) [Phase 2]
A Phase 2 trial evaluating intravenous and oral posaconazole (MK-5592) in children with invasive aspergillosis has completed, with results p…